Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02356575 · ClinicalTrials.gov registry record · NA

Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy

A NA study of Cancer and Insomnia, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
160
Enrollment target
2
Study locations

NCT02356575 is a NA study of Cancer and Insomnia that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 160 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02356575, a NA study of Cancer and Insomnia, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
2
Study locations

Study Summary

The aim of this study is to determine which of two treatments (acupuncture or cognitive behavioral therapy) works better for treating insomnia in cancer survivors. The investigator also wants to study the factors that might impact why someone might prefer or do better in one treatment over the other. Group 1 will get Acupuncture - Acupuncture is an ancient Chinese Technique of using very thin needles inserted in the skin to treat different symptoms and illness, and to promote healing. Group 2 will get Cognitive Behavioral Therapy for Insomnia (CBT-I) - CBT-I is a treatment to address behaviors and thoughts that are known to effect problems with sleep.

Conditions Studied

Interventions

  • OTHER Acupuncture
  • OTHER Cognitive Behavior Therapy

Study Locations (2)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Pennsylvania

  • Abramson Cancer Center of The University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2015-02
Est. Completion 2017-07
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT02356575

The ClinicalTrials.gov registry entry for NCT02356575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Acupuncture is the first listed.

NCT02356575 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02356575 about?

NCT02356575 is a clinical study titled "Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy". The aim of this study is to determine which of two treatments (acupuncture or cognitive behavioral therapy) works better for treating insomnia in cancer survivors. The investigator also wants to study the factors that might impact why someone might prefer or do better in one treatment over the other...

What is the current status of trial NCT02356575?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2015-02. Estimated completion is 2017-07.

What conditions does trial NCT02356575 study?

This clinical trial studies the following conditions: Cancer, Insomnia.

What interventions are being tested in trial NCT02356575?

The interventions under investigation include: Acupuncture (OTHER), Cognitive Behavior Therapy (OTHER).

Who is sponsoring clinical trial NCT02356575?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02356575 being conducted?

This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.